Offer - Urjas Oil for just ₹ 1
Macsita M Tablet is an allopathic medicine The correct dosage of Macsita M Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Macsita M Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Macsita M Tablet safe for pregnant women?
Macsita M Tablet rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Macsita M Tablet safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Macsita M Tablet. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Macsita M Tablet on the Kidneys?
Macsita M Tablet is not harmful for kidneys.
What is the effect of Macsita M Tablet on the Liver?
Macsita M Tablet is not harmful for the liver.
What is the effect of Macsita M Tablet on the Heart?
You can take Macsita M Tablet without any fear of damage to the heart.
Macsita M Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Macsita M Tablet unless your doctor advises you to do so -
Is this Macsita M Tablet habit forming or addictive?
Macsita M Tablet is not addictive in nature.
Interaction between Food and Macsita M Tablet
Due to a lack of research, nothing can be said about the consequences of taking Macsita M Tablet together with food.
Interaction between Alcohol and Macsita M Tablet
Taking alcohol with Macsita M Tablet can be dangerous.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Januvia® (sitagliptin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 274-275
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1143-1144
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826